Synthesis and Biological Evaluation of <sup>90</sup> Y-Labeled Porphyrin-DOTA Conjugate: A Potential Molecule for Targeted Tumor Therapy
Sweety Mittal(Bhabha Atomic Research Centre), M.R.A. Pillai(Unknown), Haladhar Dev Sarma(Bhabha Atomic Research Centre), Mohini Bhadwal(Bhabha Atomic Research Centre), Sharmila Banerjee(Bhabha Atomic Research Centre), Tapas Das(Bhabha Atomic Research Centre), Ashutosh Dash(Bhabha Atomic Research Centre), Rubel Chakravarty(Bhabha Atomic Research Centre)
Cited by 18
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy
|Nuclear Medicine and Biology|2008|99